Pharmaceutical News and Articles

Four-Day Work Week Benefits Workers, Employers, Study Says

TUESDAY, July 22, 2205 A four-day work week can lead to happier and more productive, dedicated employees, a new global study found.Workers at companies that ins

Dogs Can Sniff Out Parkinson's Disease, Study Shows

TUESDAY, July 22, 2025 Dogs noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect illicit drug stash

Few Schools Screen Students For Depression, Anxiety

TUESDAY, July 22, 2025 Fewer than one-third of American public schools are screening students for psychological problems, years after the U.S. Surgeon General d

Americans Braced For Loss Of Gender-Affirming Care

TUESDAY, July 22, 2025 Just about all transgender Americans believe they ll lose their access to gender-affirming health care during President Donald Trump s cu

Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease

Genentech, a member of the Roche Group (SIX RO, ROG OTCQX RHHBY), announced today topline results from the pivotal Phase IIb ALIENTO (n 1,301) and the Phase III

US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation

Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians

Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study publis

FDA Approves Prefilled Syringe Presentation for Shingles Vaccine

The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of s

Urgent Care Visits Often Linked to Inappropriate Prescribing

Urgent care visits are often associated with inappropriate prescriptions of antibiotics, glucocorticoids, and opioids, according to a research letter published

Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor ag